Immunogenicity and Protective Efficacy of Baculovirus-Expressed SARS-CoV-2 Envelope Protein in Mice as a Universal Vaccine Candidate

杆状病毒表达的 SARS-CoV-2 包膜蛋白作为通用候选疫苗对小鼠的免疫原性和保护效果

阅读:14
作者:Tuba Çiğdem Oğuzoğlu, Alireza Hanifehnezhad, Saber Delpasand Khabbazi, İlke Karayel-Hacıoğlu, Onur Kaynarcalıdan, Zehra Fırat, Nazlıcan Filazi, Eda Erdem-Şahinkesen, Buket Gül, Muhammed Cesim Karabulut, Enes Koba, Ece Adıgüzel, Elif İrem Şenlik, Emrah Korkulu, Cansu Demirden, İlker Şahinkesen, Ahmet

Abstract

The envelope (env) protein of SARS-CoV-2, a pivotal component of the viral architecture, plays a multifaceted role in viral assembly, replication, pathogenesis, and ion channel activity. These features make it a significant target for understanding virus-host interactions and developing vaccines to combat COVID-19. Recent structural studies provide valuable insights into the conformational dynamics and membrane topology of the SARS-CoV-2 env protein, shedding light on its functional mechanisms. The strong homology and highly conserved structure of the SARS-CoV-2 env protein shape its immunogenicity and functional characteristics. This study examines the ability of the recombinant SARS-CoV-2 env protein to stimulate an immune response. In this study, recombinant envelope proteins were produced using the baculovirus expression system, and their potential efficacy was evaluated in both in vivo and in vitro models. Our results reveal that the env protein of SARS-CoV-2 stimulates humoral and cellular responses and highlight its potential as a promising vaccine candidate for combating the ongoing pandemic.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。